Industry ownership intelligence

Medical Devices insider conviction

Executive and director activity assessed across 82 companies for breadth, transaction quality, clustering, freshness, and directional conviction.

Market dashboardHealthcare sectorCompany signalsFiling ledgerData API
47/100

Balanced insider tape

90/100 confidence
Level
Industry
Evidence window
Latest 90 days
Named insiders
656
Latest evidence
7 Aug 2026

Capital positioning read

Balanced insider tape

Acquisition and disposal evidence is mixed after low-information compensation and derivative activity is separated out.

Wait for clearer clustering

Evidence in favour

  • 135 distinct acquisition events survive duplicate and security-type controls.
  • Participation spans 656 named insiders rather than one filing source.
  • The latest qualifying evidence is fresh, dated 07 Aug 2026.

Decision risks

  • Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Conviction47Balanced insider tape
Confidence90Deep evidence
Controlled events548directional common-share events
Company breadth82represented companies
Acquisition value$28.9Mnormalized amount
Disposal value$275.6Mnormalized amount

Flow regime

Twelve-week filing pressure

Shows the cadence and balance of the full filing tape.

15825 May
30901 Jun
16008 Jun
15715 Jun
7922 Jun
11129 Jun
7006 Jul
4213 Jul
3120 Jul
8227 Jul
5303 Aug
010 Aug
AcquisitionsDisposalsScore 47 · Confidence 90

Relative positioning

Industry peer map

Current score with confidence.

Pharmaceutical RetailersConviction accumulation7216 confidence Medical DistributionConviction accumulation6874 confidence Drug Manufacturers - GeneralBalanced insider tape5694 confidence BiotechnologyBalanced insider tape5391 confidence Medical DevicesBalanced insider tape4790 confidence Diagnostics & ResearchDistribution bias3894 confidence Medical Care FacilitiesDistribution bias3793 confidence Medical Instruments & SuppliesDistribution bias3791 confidence Healthcare PlansDistribution bias3692 confidence Health Information ServicesDistribution bias3691 confidence Drug Manufacturers - Specialty & GenericDistribution bias3594 confidence

Directional balance

Controlled event mix

24.6%acquisition
Acquisition events
135
Disposal events
413
Net value
-$246.7M

Evidence quality

What the filings represent

Common equity1127
Equity compensation332
Options and derivatives238
Other securities10

Decision makers

Role participation

Director893
Other executive332
CEO and chair165
Finance leadership139
Other or unspecified124
Large holder54

Quality controls

Evidence usability

Normalized values
35%
Priced common share
34%
Named insiders
656
Controlled events
548

Auditable evidence

Latest Medical Devices filings

Showing 721 to 750 of 1707.

OFIXOrthofix Medical Inc
PAOLUCCI, MICHAEL EDirector
AcquisitionCommon equity
Not reportedContext evidence
TMCITreace Medical Concepts Inc
TREACE, JOHN T.Director, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
$118.4KDirectional evidence
SGHTSight Sciences Inc
ENCRANTZ, STAFFANDirector, 10% Owner
AcquisitionCommon equity
$68.8KDirectional evidence
TMCITreace Medical Concepts Inc
TREACE, JOHN T.Director, Chief Executive Officer, 10% Owner
AcquisitionCommon equity
$59.2KDirectional evidence
ENOVEnovis Corp
ENGERT, OLIVERChief Administrative Officer
AcquisitionCommon equity
$23.0KDirectional evidence
KIDSOrthopediatrics Corp
BAILEY, DAVID RDirector, President and CEO
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
DYER, GEORGE SINCLAIR MITCHELLDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
FISCHER, KELLY LAINEDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
HUGHES, BRYAN WDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
INFANTE, (REYNOLDS) MARIE CDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
MCDONALD, JIMMY DUANEDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
PELIZZON, DAVID RDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
RICCITELLI, SAMUEL DDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
RUF, HAROLDDirector
AcquisitionCommon equity
Not reportedContext evidence
KIDSOrthopediatrics Corp
THRODAHL, MARK CDirector
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
DESAI, ANTAL ROHITDirector
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
DESAI, ANTAL ROHITDirector
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
DODRILL, AMY M.Director
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
DODRILL, AMY M.Director
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
GARRETT, MARYDirector
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
GARRETT, MARYDirector
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
HARRIS, TAYLOR C.Director
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
HARRIS, TAYLOR C.Director
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
LITTLE, ELISABETH SANDOVALDirector
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
LITTLE, ELISABETH SANDOVALDirector
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
MOLL, FREDERIC HDirector
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
MOLL, FREDERIC HDirector
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
PRESCOTT, THOMAS MDirector
AcquisitionCommon equity
Not reportedContext evidence
PRCTProcept Biorobotics Corp
PRESCOTT, THOMAS MDirector
AcquisitionOptions and derivatives
Not reportedContext evidence
PRCTProcept Biorobotics Corp
PUCKETT, DANDirector
AcquisitionOptions and derivatives
Not reportedContext evidence

Group-level method

Breadth before headline value

Company breadth

A sector or industry score must be supported across companies. One very large filing cannot manufacture broad conviction.

Economic duplicates

Matching company, date, side, security class, share count, and value records are consolidated for the directional calculation.

Evidence hierarchy

Priced common-share activity determines direction. Compensation and derivative records are mapped separately so ownership mechanics remain visible.

Positioning use

The score identifies where insider alignment merits research or where disposal concentration needs review. Price, trend, valuation, and portfolio risk still decide positioning.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context